Sulfamethomidine

Suppliers

Names

[ CAS No. ]:
3772-76-7

[ Name ]:
Sulfamethomidine

[Synonym ]:
Methofazine
N1-<6-Methoxy-2-methyl-pyrimidinyl-(4)>-sulfanilamid
4-amino-N-(6-methoxy-2-methyl-pyrimidin-4-yl)-benzenesulfonamide
Duroprocin
Sulfametomidina [INN-Spanish]
Sulfamethomidine
Sulfametomidine
Methofadin
Sulfanilsaeure-(6-methoxy-2-methyl-pyrimidin-4-ylamid)
sulfanilic acid-(6-methoxy-2-methyl-pyrimidin-4-ylamide)
SA 412
EINECS 223-219-5
Sulfametomidinum [INN-Latin]
Solfametomidina [DCIT]
4-<4-Amino-benzolsulfonylamino>-6-methoxy-2-methyl-pyrimidin
Sulfamethomidin

Chemical & Physical Properties

[ Density]:
1.418g/cm3

[ Boiling Point ]:
501.6ºC at 760mmHg

[ Molecular Formula ]:
C12H14N4O3S

[ Molecular Weight ]:
294.33000

[ Flash Point ]:
257.2ºC

[ Exact Mass ]:
294.07900

[ PSA ]:
115.58000

[ LogP ]:
2.91160

[ Index of Refraction ]:
1.633

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
WP0110000
CHEMICAL NAME :
Sulfanilamide, N(sup 1)-(6-methoxy-2-methyl-4-pyrimidinyl)-
CAS REGISTRY NUMBER :
3772-76-7
BEILSTEIN REFERENCE NO. :
0284949
LAST UPDATED :
199612
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C12-H14-N4-O3-S
MOLECULAR WEIGHT :
294.36
WISWESSER LINE NOTATION :
T6N CNJ B1 DO1 FMSWR DZ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
3 gm/kg
SEX/DURATION :
female 9-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
REFERENCE :
SEIJBO Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. Volume(issue)/page/year: 13,17,1973
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
6 gm/kg
SEX/DURATION :
female 9-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
REFERENCE :
SEIJBO Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. Volume(issue)/page/year: 13,7,1973
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
3 gm/kg
SEX/DURATION :
female 7-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
REFERENCE :
SEIJBO Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. Volume(issue)/page/year: 13,17,1973

Safety Information

[ HS Code ]:
2935009090

Synthetic Route

Precursor & DownStream

Precursor

  • 4-Pyrimidinamine, 6-methoxy-2-methyl- (9CI)
  • 4-Acetamidobenzenesulfonyl chloride
  • N-[4-[(6-methoxy-2-methylpyrimidin-4-yl)sulfamoyl]phenyl]acetamide
  • 4,6-Dichloro-2-methylpyrimidine
  • 4-Acetamidobenzenesulfonamide

DownStream

Customs

[ HS Code ]: 2935009090

[ Summary ]:
2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%


Related Compounds

  • 5-bromo-N-(1-propanoyl-1,2,3,4-tetrahydroquinolin-6-yl)furan-2-carboxamide
  • 2,3,4,6-Tetrafluoro-5-iodopyridine
  • 2-oxo-N-{4-[4-(propan-2-yl)phenyl]-1,2,5-oxadiazol-3-yl}-2H-chromene-3-carboxamide
  • 2-Bromo-1-(3-methylphenyl)-2-(2-methyl-4-pyridyl)ethanone hydrocbromide
  • 4-Ethoxy-butyraldehyde
  • Pentacyclo[6.3.0.0^{2,6}.0^{3,10}.0^{5,9}]undecane-4-carboxylic acid
  • 2-amino-N-[(E)-[(4,6-dimethylpyrimidin-2-yl)amino]{[2-(5-methoxy-1H-indol-3-yl)ethyl]amino}methylidene]benzamide
  • 1,1'-Bis[[2-(trimethylsilyl)ethoxy]methyl]-2,2'-bi-1Himidazole
  • 5-Chloro-2-methanesulfonyl-1H-benzimidazole
  • trans-4-n-Pentyl-4'-(4-n-pentylcyclohexyl)biphenyl
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.